Advanced Acne Spot Treatment

Product NDC
59779-343
11-digit product format
597790343
Labeler code
59779
Product ID
59779-343_495e462d-4721-43fa-87b6-e7386ddd0338
Type
HUMAN OTC DRUG
Nonproprietary name
Salicylic Acid 2.00%
Dosage form
LOTION
Route
TOPICAL
Labeler
CVS
Application
part333D
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2014-12-22
Marketing end
0000-00-00
Substance
SALICYLIC ACID
Active strength
2 g/100mL
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct59779-343IInactivated by FDA2026-10-12
excluded packagepackage59779-34359779-343-01IInactivated by FDA2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage59779-343-01d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage59779-343-01f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage59779-343-012ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage59779-343-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage59779-343-01cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage59779-343-01cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage59779-343-01302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage59779-343-01ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage59779-343-010efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage59779-343-01ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage59779-343-01367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage59779-343-01557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage59779-343-018af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage59779-343-01834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage59779-343-011332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage59779-343-01fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproduct86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage59779-343-0186f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage59779-343-01bd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproduct8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage59779-343-018dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproducte2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage59779-343-01e2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproduct9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage59779-343-019bebd1f3094a…5416666fcb17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59779-343-012020-01-31C16284748780-19d75b9d0-177a-f424-e053-dadaa90a57ce439e6506-40a6-4dce-80db-11dbe6d55fc3

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59779-343-01Advanced Acne Spot TreatmentCVS1 in 1 CARTONLOTION12
59779-343-01Advanced Acne Spot TreatmentCVS22 mL in 1 TUBELOTION222

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Salicylic AcidACTIVE INGREDIENTO414PZ4LPZADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
AlcoholINACTIVE INGREDIENT3K9958V90MADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
AMMONIAINACTIVE INGREDIENT5138Q19F1XADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Benzalkonium ChlorideINACTIVE INGREDIENTF5UM2KM3W7ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Butylene GlycolINACTIVE INGREDIENT3XUS85K0RAADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
C12-15 Alkyl LactateINACTIVE INGREDIENTGC844VRD7EADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
C13-14 IsoparaffinINACTIVE INGREDIENTE4F12ROE70ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Capryloyl GlycineINACTIVE INGREDIENT8TY5YO42NJADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
CEDRUS ATLANTICA BARKINACTIVE INGREDIENTITP1Q41UPFADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Cetyl LactateINACTIVE INGREDIENTA7EVH2RK4OADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
CINNAMON BARK OILINACTIVE INGREDIENTXE54U569ECADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Cocamidopropyl PG-Dimonium Chloride PhosphateINACTIVE INGREDIENTH2KVQ74JM4ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0RADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Dehydroxanthan GumINACTIVE INGREDIENT63ZP7I1BQOADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Denatonium BenzoateINACTIVE INGREDIENT4YK5Z54AT2ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
DimethiconeINACTIVE INGREDIENT92RU3N3Y1OADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
EDETATE SODIUMINACTIVE INGREDIENTMP1J8420LUADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
GlycerinINACTIVE INGREDIENTPDC6A3C0OXADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
HAMAMELIS VIRGINIANA TOPINACTIVE INGREDIENTUDA30A2JJYADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Hexylene GlycolINACTIVE INGREDIENTKEH0A3F75JADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Laureth-7INACTIVE INGREDIENTZ95S6G8201ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
PhenoxyethanolINACTIVE INGREDIENTHIE492ZZ3TADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Polysorbate 20INACTIVE INGREDIENT7T1F30V5YHADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
PPG-2 Isoceteth-20 AcetateINACTIVE INGREDIENTBI6C7YO419ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
Propylene GlycolINACTIVE INGREDIENT6DC9Q167V3ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
PURSLANEINACTIVE INGREDIENTM6S840WXG5ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
SarcosineINACTIVE INGREDIENTZ711V88R5FADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER (1:1; 90000-150000 MPA.S)INACTIVE INGREDIENT5F4963KLHSADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
TERT-BUTYL ALCOHOLINACTIVE INGREDIENTMD83SFE959ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1
WaterINACTIVE INGREDIENT059QF0KO0RADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59779-343ADVANCED ACNE SPOT TREATMENT CVS (SALICYLIC ACID 2.00%) LOTION [CVS]2Legacy NDC, 2 package rows20171226_439e6506-40a6-4dce-80db-11dbe6d55fc3.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
103568salicylic acid 2 % Topical LotionPSN439e6506-40a6-4dce-80db-11dbe6d55fc32
103568salicylic acid 20 MG/ML Topical LotionSCD439e6506-40a6-4dce-80db-11dbe6d55fc32
103568salicylic acid 2 % Topical LotionSY439e6506-40a6-4dce-80db-11dbe6d55fc32

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
59779-343-01597790343011 in 1 CARTONHistorical